Attached files
file | filename |
---|---|
10-K - FORM 10-K - Nascent Biotech Inc. | nbio_10k.htm |
EX-32.1 - CERTIFICATION - Nascent Biotech Inc. | nbio_ex321.htm |
EX-31.2 - CERTIFICATION - Nascent Biotech Inc. | nbio_ex312.htm |
EX-31.1 - CERTIFICATION - Nascent Biotech Inc. | nbio_ex311.htm |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Nascent Biotech, Inc. on Form 10-K for the year ended March 31, 2016 (the "Form 10-K"), as filed with the Securities and Exchange Commission, Lowell Holden, Chief Financial Officer of the Company, does hereby certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
The Form 10-K fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operation of Nascent Biotech Inc.
1. 2.
Dated: July 14, 2016 | By: | /s/ Lowell Holden | |
Lowell Holden - Chief Financial Officer |
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.